Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review

Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review

Background/Aims: The term monoclonal gammopathy of renal significance (MGRS) was introduced in 2012 to emphasize kidney lesions in monoclonal gammopathy patients. Bortezomib-based chemotherapy has become the first-line treatment for MGRS. Objectives: The objective of this study was to investigate wh...

Full description

Bibliographic Details
Main Authors: Jing Huang, Chunyan Sun, Hua Su, Chun Zhang, Jing Xiong
Format: Article
Language:English
Published: Karger Publishers 2019-07-01
Series:Kidney & Blood Pressure Research
Subjects:
Bortezomib
Autologous stem cell transplantation
Monoclonal gammopathy of renal significance
Online Access:https://www.karger.com/Article/FullText/501314

Similar Items

Similar Items